Home > Collections > Topics in Regulatory Affairs for Pharmaceuticals
Topics in Regulatory Affairs for Pharmaceuticals
View PDF

Topics in Regulatory Affairs for Pharmaceuticals

Publisher: FX Conferences
  • Description

Stay current on the ever-changing regulatory environment with 10 audio recordings of industry experts offering practical guidance for executives, directors, managers, and associates concerned with regulations in the pharmaceutical market.

Ovid and FX Conferences offer thousands of professional development hours for your teams, conveniently packaged and delivered as a collection of audio recordings to save you time and money.

Topics in this collection have a global appeal and are relevant for multiple departments within your organization—R & D, Market Research, Compliance, and more. Each of the 10 recordings consists of a 45-minute, telephone-based presentation delivered by expert international speakers, followed by a 15-minute question-and-answer session (collection available with and without transcripts).

RECORDINGS:

1. Requests for Off-label Information – The FDA Guidance and Its Implications
Speakers: Wendy Blackburn, Executive Vice President, Intouch Solutions, and Dr. Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm

2. Preparing for Upcoming Changes in EU Pharmacovigilance Requirements
Speaker: Dr. Jan Petracek, CEO & Chief Consultant, PharmInvent

3. Industry Update – Europe's New Pharmacovigilance Regulations
Speaker: Stefan Blesse, Principal Consultant, Granzer Regulatory Consulting & Services

4. Effectively Managing an FDA Inspection – Opening Meeting to Rapid 483 Response
Speaker: John Avellanet, Managing Director & Principal, Cerulean Associates LLC

5. FDA Update – Responding to Unsolicited Requests for Off-Label Information
Speakers: Marian J. Lee, Partner, and Beverly H. Lorell, Senior Adviser, King & Spalding LLP

6. Centralized vs Onsite Monitoring – Applying FDA's Risk-based Approach
Speaker: Sandra Maddock, President & CEO, IMARC Research, Inc

7. Off-label Promotion – What FDA Looks For & What You Need to Know
Speaker: Alan Minsk, Partner, Arnall Golden Gregory LLP

8. Expedited and Periodic Safety Reporting for Drug Trials
Speakers: Helen Colquhoun, Vice President, Cromsource

9. Following the 510(k) and 505(b)(2) Pathways to Regulatory Approval
Speaker: Dr. Joy Frestedt. President & CEO, Frestedt Incorporate

10. Successfully Responding to FDA 483s and Warning Letters
Speaker: Michael A. Swit, Special Counsel, FDA Practice, Duane Morris LLP

Free Instant Access
This Month

JOTM
Biomedical Research Grants—UberResearch NEW! UberResearch is a searchable database of awarded research funding that includes more than 600,000 indexed records. And now it's available on the Ovid® platform!
JOTM
The Philosopher's Index The Philosopher's Index is a bibliographic database with informative author-written abstracts covering scholarly research in the fifteen fields of philosophy, published in journals and books since 1940.
JOTM
Evidence-Based Practice Evidence-Based Practice is a quarterly journal focused on topics relevant to the daily practice of family medicine and includes content addressing timely and pertinent questions related to patient care.
JOTM
Stroke An official journal of the American Heart Association, Stroke publishes reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases from many disciplines.

Noteworthy

Doody's Featured Books
Shields' General Thoracic Surgery, 8th Edition
Your #1 resource for comprehensive coverage of both open and endoscopic surgical techniques, with commentary from more than 150 global experts in the field.

The Washington Manual of Echocardiography, 2nd Edition
Essential information you need to successfully perform and read echocardiograms, as well as to identify valvular heart disease, cardiac myopathies, and congenital anomalies.